Arlington Capital Management, Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1606507
ARLINGTON HEIGHTS, IL
Position in VRTX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$397,384
+$40,152 QoQ
Shares Held
800
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#1,140
of 1,735 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Arlington Capital Management, Inc. holds $788,194 across 2 Biotechnology names. VRTX ranks #1 (50.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
800 | $397,384 | |
| 2 | BNTX |
BioNTech SE
|
4,200 | $390,810 |
All Filings in VRTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $397,384 | 800 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $357,232 | 800 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $362,688 | 800 | Shares | Sole | 2026-01-06 | |
| No filing history on record for this holder in this stock. | ||||||